Celestial Biolabs Limited reported earnings results for the third quarter and nine months ended December 31, 2023. For the third quarter, the company reported sales was INR 0.368 million compared to INR 0.338 million a year ago. Revenue was INR 0.368 million compared to INR 0.338 million a year ago. Net loss was INR 0.362 million compared to INR 1.53 million a year ago. Basic loss per share from continuing operations was INR 0.02 compared to INR 0.07 a year ago. Diluted loss per share from continuing operations was INR 0.02 compared to INR 0.07 a year ago.
For the nine months, sales was INR 0.952 million compared to INR 1.31 million a year ago. Revenue was INR 0.952 million compared to INR 1.31 million a year ago. Net loss was INR 1.65 million compared to INR 3.36 million a year ago. Basic loss per share from continuing operations was INR 0.07 compared to INR 0.15 a year ago. Diluted loss per share from continuing operations was INR 0.07 compared to INR 0.15 a year ago.